CME Information:
Commercial Support
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.
Credits Available
- Physicians - maximum of 1.0 AMA PRA Category 1 Credit™
- ABIM MOC – up to 1.0 MOC points
- Nurses – 1.0 contact hour
- Pharmacists – 1.0 contact hour (.10 CEUs)
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
Cardiologists, endocrinologists, lipidologists (adult and pediatric), pediatricians, pharmacists, primary care clinicians, including advanced practice providers, and nurses.
Program Overview
Explore expert-led strategies to identify and treat pediatric HoFH early. This case-based program covers screening, diagnosis, treatment escalation, and real-world challenges, helping clinicians improve outcomes and prevent early cardiovascular disease in affected children.
Learning Objectives
At the end of this activity, all participants should be able to:
- Recognize risk factors that justify the need for lipid testing and/or cascade screening for HoFH
- Discuss the mechanisms of action and efficacy and safety data for newer agents for HoFH in children and adults
- Characterize caregiver and patient education approaches that facilitate understanding of risks associated with insufficiently managed HoFH
- Discuss strategies to improve the knowledge, skills or performance of the healthcare team
Faculty
Carissa Baker-Smith, MD, MPH
Julie A. Brothers, MD, FACC
Sean Thompson
Parent of child with HoFH
Credit Designation
CME/CE credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by MedliveCME and the National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Pharmacist Accreditation Statement
Universal Activity Number Application JA0007192-0000-26-007-H01-P (Application)
This Activity has been approved for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education
Nursing
The maximum number of hours awarded for this CE activity is 1.0 contact hours.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. Partial credit may be awarded for ACPE credit. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. The deadline to claim credit is March 19, 2027.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
*IMPORTANT* Pharmacists MUST request credit before March 19, 2027. Credit requested after this date will be subject to a fee by the accreditation board.
Disclosure Information
Carissa Baker-Smith, MD, MPH
Speaker: Merck Pharmaceuticals
Julie A. Brothers, MD, FACC
Speaker: Regeneron
Sean Thompson
Parent of child with HoFH
Nothing to disclose.
NLA staff have no relevant financial information to disclose.
NLA CME Committee Reviewers:
Scott Shurmur, MD
Consultant - Akcea
Disclosure of Unlabeled Use and Investigational Products
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclosure Declaration
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.
Permissions
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.
Contact Information
Accreditation Support: For information about the accreditation of this program, please contact NLA at 904-998-0854 or [email protected]
Technical Support: For any technical issues or issues with your CME Certificate, please contact Medlive at 877-394-1306 or at [email protected].
PlatformQ Health Privacy Policy
By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at [email protected]
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting [email protected] with the subject line “Data Request”
You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/